top of page
Contact Us
Contact Us

Global Venetoclax comparator supply for oncology clinical trials

CSI has significant experience sourcing Venetoclax for oncology clinical trials worldwide. Frequently used in combination with Azacitidine for the treatment of acute myeloid leukaemia (AML), our team can source both medicines as part of a coordinated comparator supply strategy, simplifying procurement and ensuring continuity throughout your study.

Venclyxto® (venetoclax) Comparator Sourcing

5j82ljb8_keytruda_625x300_14_April_26_edited.jpg

The clinical supply partner of choice

venetoclax is on the critical path of a large share of active oncology programmes, and demand routinely outstrips the volume available through a single market. Sponsors running multi‑country studies need a partner who can hold continuity of supply across regions, not a broker who can fulfill one order. CSI's scientific team builds the sourcing strategy around your protocol: which presentations the sites require, which markets can supply them compliantly, and how far ahead the volume has to be secured. That work is what keeps a study on schedule when the market tightens. Every unit arrives with the documentation your QP and regulatory teams expect, sourced through qualified manufacturers and wholesalers inside a fully traceable chain.

THE CSI PROCESS

From protocol to site in six weeks

Six steps, one project manager, full documentation at every handover.

Protocol and brief

Our scientific team reviews your protocol, confirms the comparator specification and models quantities per country, per arm and per visit schedule. You get a written sourcing strategy, not a price list.

02

Feasibility and market mapping

We map licensed markets, batch availability, shelf life and pricing across a network of more than 200 audited manufacturers and suppliers, and flag any market where continuity is at risk before you commit.

03

Sourcing and authentication

Product is purchased manufacturer-direct or through audited wholesale channels, with full chain of custody from the point of manufacture. Every unit is authenticated before it enters our depots.

04

QP release and documentation

Certificates of Analysis, chain of custody, purchase invoices and country-specific regulatory documentation are assembled for import and Qualified Person release in each destination market.

05

Cold chain delivery

Validated 2–8 °C shipping to depot or direct-to-site, with continuous temperature monitoring and GDP-compliant handling across 60 countries on six continents.

06

Resupply and forecasting

Rolling demand forecasts, shelf-life control and batch reservation for the life of the study, with one project manager accountable from first shipment to reconciliation.

What every Venclyxto® order gets from CSI

Global sourcing of Venetoclax and Azacitidine
Both products sourced together as a single coordinated comparator supply.
Coordinated supply for combination therapy studies
Aligned delivery so neither arm of the combination waits on the other.
Manufacturer and market sourcing strategies
Routes selected per market to protect continuity across a long programme.
Temperature-controlled global distribution
GDP-compliant cold chain with continuous monitoring and excursion reporting.
Certificates of Analysis and supporting regulatory documentation
Batch-specific documentation supplied with every shipment.

COLD CHAIN

Three temperature regimes, one validated

venetoclax ships at 2 to 8°C, but a comparator programme rarely ships one product alone. CSI validates the full range so combination and concomitant supply moves together

2 to 8°C

REFRIGERATED

Venclyxto® and the majority of biologic comparators. Continuous monitoring, qualified shippers, excursion reporting.

−20°C

FROZEN

Venclyxto® and the majority of biologic comparators. Continuous monitoring, qualified shippers, excursion reporting.

−80°C

ULTRA-LOW

Venclyxto® and the majority of biologic comparators. Continuous monitoring, qualified shippers, excursion reporting.

PRODUCT DETAIL

Presentations we supply

100 mg/4 mL vial

Legacy

Form

Powder for concentrate for solution for infusion

Pack

Single Lyophilised vial × 1

Storage

2–8 °C, protect from light

Markets

Global

Typical lead time

On enquiry

Why sponsors choose CSI

150+ years of clinical trial supply experience and a scientific team that reads the protocol before it quotes.

Over 1,200 clinical trials supported
Direct relationships with 200+ manufacturers
Dedicated scientific project management team
Expertise in oncology, biosimilars and immunology
Access to 15,000+ medicines
Warehousing and distribution across 60 countries
GDP-compliant cold chain at every temperature
Full regulatory documentation with every shipment

Documentation

  • Batch-specific analytical results confirming the product meets its registered specification. Supplied for every batch, in the language your regulatory submission requires

  • A signed declaration that the product is genuine and was acquired through the licensed supply chain, with the purchase route documented. This is the assurance against falsified or diverted product when a comparator is bought on the open market.

  • A signed declaration that the product is genuine and was acquired through the licensed supply chain, with the purchase route documented. This is the assurance against falsified or diverted product when a comparator is bought on the open market.

  • Monitoring data for every shipment, with any deviation from the required range logged, reported and assessed for impact on product quality. You receive the record whether or not an excursion occurs.

  • A documented record of every party that held the product between the source market and your investigator site, with dates and handover points. What you need to evidence an unbroken, traceable route at inspection.

CASE STUDY

Oncology product batch hunting

How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets.

Challenge

A sample from each batch had to be tested before purchasing the bulk.
Solution

We hunted specific batches in European markets where batch visibility was possible.
Result

The product was delivered in full and the client’s trial never ran dry.

APPLICATIONS

Where sponsors use Venclyxto® as comparator

Pharmacy Shelf Medication

Oncology

Comparator and standard-of-care supply for solid tumour and haematology programmes across all phases.

Microscopic Cell Clusters

Immunotherapy

Checkpoint inhibitor sourcing for combination and head-to-head study designs.

Microscope Close-Up

Biosimilar development

Originator reference product sourced to meet regional regulatory requirements.

FAQ

Venclyxto® sourcing, answered

Can CSI supply venetoclax as a comparator for a global study?

Yes. CSI sources Venclyxto® (venetoclax) for oncology trials across Europe, North America, Latin America and Asia-Pacific. Our scientific team reviews your protocol, models quantities and builds a country-by-country sourcing strategy before any purchase is committed.

Can venetoclax and azacitidine be supplied together?

Yes. Venetoclax is frequently used with azacitidine in acute myeloid leukaemia. CSI can source both as a single coordinated comparator supply, so neither arm of the combination waits on the other.

How long does comparator sourcing for venetoclax take?

Every study is different, and sourcing timelines depend on your specific requirements, market, quantity and documentation needs. Send us your study requirements and product details, and we will assess what is possible for your programme. Where a study is at risk, CSI has compressed sourcing timelines by working directly with manufacturers.

What documentation is supplied with the product?

The availability of supporting documentation depends on the country from which the product is sourced and the specific requirements of the study. Where available, CSI can provide documentation such as Certificates of Analysis and country-specific regulatory documentation at an additional cost.

How is venetoclax stored and shipped?

Venetoclax is an oral solid dose and ships under controlled ambient conditions with temperature monitored in transit, rather than on a 2-8 °C cold chain. Where a protocol also requires refrigerated or frozen product, CSI operates GDP-compliant depots in 60+ countries and manages 2-8 °C, -20 °C and -80 °C alongside it.

Talk to our comparator sourcing specialists

Send us the protocol, the markets and the timeline. Our scientific team will come back with a sourcing strategy for your Venclyxto® requirement.

bottom of page